`
`University of Maryland, Baltimore
`IPR2016‐00208
`
`PETITIONER NEOCHORD’S
`
`DEMONSTRATIVESDEMONSTRATIVES
`
`Neochord v University of Maryland BaltimoreNeochord v. University of Maryland, Baltimore
`
`IPR2016‐00208
`Petitioner Neochord Exhibit 1016
`
`
`
`
`
`Outline of ArgumentOutline of Argument
`
`• Speziali is prior art to the ‘386 PatentSpeziali is prior art to the 386 Patent.
`
`• “Percutaneously accessing” encompasses
`
`procedures that utilize an incision in the skinprocedures that utilize an incision in the skin.
`• The Grounds based on Speziali should be
`
`i dimaintained.
`
`• The Grounds based on Lattouf I should be
`maintained.
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 1
`
`
`
`Speziali is Exclusively Licensed
`to Petitioner
`
`– Petition, p. 20, n. 6.
`• Claim 1 of Speziali PCT application as filed:p pp
`
`
`• NeoChord is the exclusive licensee of Spezialip
`
`
`
`– Ex. 1013, p. 11
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 2
`
`
`
`
`
`Speziali is prior art to the ‘386 PatentSpeziali is prior art to the 386 Patent
`
`— ‘386 Patent priority claim (Ex. 1001, 1:7‐10)
`
`— Speziali priority claim (Ex. 1006, 1:7‐14)
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 3
`
`
`
`
`
`Speziali is a PCT Nat’l Stage ApplSpeziali is a PCT Nat l Stage Appl
`
`• “An international application designating theAn international application designating the
`
`United States shall have the effect, from its
`
`international filing date under article 11 ofinternational filing date under article 11 of
`the treaty, of a national application for patent
`
`regularly filed in the Patent and Trademarkregularly filed in the Patent and Trademark
`Office.”
`
`
`– 35 U.S.C. § 363 cited at Reply, pp. 9‐10.§ p y, pp
`
`
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 4
`
`
`
`There is no special definition of
`
`““percutaneously accessing”l ”
`
`
`
`• Petition:Petition:
`
`– Petition, p. 12.
`• Board decision:
`
`– Decision, p. 8.
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 5
`
`
`
`Ordinary meaning of “percutaneous”
`“ his “through the skin”h h k ”
`
`
`
`
`• Petitioner’s expert:Petitioner s expert:
`
`– Ex. 2004, 24:4‐6.
`
`• Patentee’s expert:• Patentee s expert:
`
`– Ex. 2001, para. [0039].
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 6
`
`
`
`Ordinary meaning of “transmyocardial” Ordinary meaning of “transmyocardial”
`
`is “through the heart wall”
`
`• Petitioner’s expert:Petitioner s expert:
`
`– Ex. 2004, 69:2‐5.
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 7
`
`
`
`Patentee’s construction of
`“percutaneously accessing” is wrong
`
`• Patentee:Patentee:
`
`
`
`– Response, p. 2Response, p. 2
`
`– Reply, p. 4
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 8
`
`
`
`Transmyocardial access does not
`lrequire or relate to unbroken skinb k k
`
`
`
`
`• Patentee’s evidence:Patentee s evidence:
`
`– Ex. 2007, p. 8.
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 9
`
`
`
`The ‘386 Patent teaches use of an
`fincision for percutaneous access
`
`
`• The ‘386 Patent:The 386 Patent:
`
`– Col. 11, ll. 35‐52.
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 10
`
`
`
`The ‘386 Patent also teaches direct
`dlneedle access can utilize an incisionl
`
`
`
`• The ‘386 Patent:The 386 Patent:
`
`– Ex. 1001, 7:40‐44.
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 11
`
`
`
`The Grounds based on Speziali
`
`ld bhshould be maintainedd
`
`
`
`• Patentee’s sole argument on claims 1‐4 and 7‐14 is g
`that Speziali was not prior art.
`– Response, pp. 16.
`
`• Patentee’s only additional argument on claims 19• Patentee s only additional argument on claims 19,
`22 and 23 relies entirely on construction of
`“percutaneously” excluding any use of an incision.
`– Response, pp. 13‐15.
`• Patentee confuses Speziali’s teaching of a line
`
`incision for percutaneous access with Speziali’sincision for percutaneous access with Speziali s
`teaching of a stab incision for transmyocardial
`access.
`
`Response pp 14 15– Response, pp. 14‐15.
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 12
`
`
`
`Combining Speziali and Bachman
`bis Obvious
`
`
`• Patentee’s sole argument that claims 5‐6, 18Patentee s sole argument that claims 5 6, 18
`and 20‐21 is attorney argument that Speziali
`and Bachman would not be combined:
`– Response, pp. 19‐26; Reply, p. 17.
`
`
`
`• Speziali (transapical)Speziali (transapical)
`
`
`
`• Bachman (endovascular)Bachman (endovascular)
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 13
`
`
`
`The Grounds based on Lattouf I
`
`ld bhshould be maintainedd
`
`
`
`• Lattouf I in view of BachmanLattouf I in view of Bachman
`– (claims 1, 4‐6 and 19‐21).
`• Lattouf I in view of CarpentierLattouf I in view of Carpentier
`
`– (claims 1‐9, 11‐15, 17‐19, 22 and 23).
`• Lattouf I in view of DowningLattouf I in view of Downing
`
`– (claims 1, 3, 4, 5, and 19).
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 14
`
`
`
`All Secondary References Teach a
`lSuture Directly With a Leafleth fl
`
`
`
`
`• Carpentier:p
`
`– Ex. 1009, p. 328.
`• Bachman:
`
`– Ex. 1008, Fig. 10.
`• Downing:
`
`– Ex. 1005, 15:6‐9.
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 15
`
`
`
`Lattouf I also Teaches a Suture Directly
`hwith a Leafletfl
`
`
`
`
`
`• Lattouf ILattouf I
`
`– Decision, p. 20, n. 12.
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 16
`
`
`
`Lattouf I Discloses a Trocar for
`d lTransmyocardial Access
`
`
`• Patentee’s expert:Patentee s expert:
`
`– Ex. 2001, para. 55.
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 17
`
`
`
`Combining Lattouf I and Any of the
`dSecondary References is Obviousf b
`
`
`
`
`• Patentee’s attorney arguments are not against y g g
`
`
`the combination, but only against the references
`in isolation
`
`– Reply pp 18‐25Reply, pp. 18 25.
`• For claim 20 and 21, Bachman further teaches
`how the device of Lattouf I could be used
`
`dendovascularly. l l
`
`
`– Reply pp. 20‐22.
`
`• No separate evidence is presented for dependentNo separate evidence is presented for dependent
`claims 2‐9, 10‐18 and 22‐23 for the grounds
`based on Lattouf I.
`
`NeoChord v. Univ. of Maryland – IPR2016‐00208
`NeoChord Ex. 1016
`
`Page 18
`
`